1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsFiscal Sponsorship Program is sponsored by Multidisciplinary Association for Psychedelic Studies (MAPS). MAPS' fiscal sponsorship program empowers grassroots projects aligned with its mission, which includes psychedelic harm reduction, drug policy reform, and education.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Fiscal Sponsorships – Multidisciplinary Association for Psychedelic Studies – MAPS MAPS' Fiscal Sponsorships Empowers Grassroots Projects Over 10 years , nearly 70 mission-aligned groups around the world have advanced the movements for psychedelic harm reduction, drug policy reform, and education with support from MAPS.
A fiscal sponsorship is an empowering collaboration between MAPS and the operators of independent projects aligned with our mission. Our program is structured as a grantor-grantee relationship, meaning that donors are able to make tax-deductible contributions to MAPS in support of the charitable project, and MAPS then re-grants these funds to the sponsored entity that operates the project.
This model can be thought of as a partnership for progress, catalyzing innovative community initiatives and expanding MAPS’ overall impact. Fiscal sponsorship projects expand the psychedelic ecosystem through education, research, advocacy and community-building initiatives. "The Fiscal Sponsorship program has been critical to building the psychedelic ecosystem.
It’s been one of the most important programs that MAPS has conducted. We have helped organizations in psychedelics get their start like Erowid, DanceSafe, Chacruna, and many others." Fiscally Sponsored Projects in the Media From Stigma to Science: Deva Collective founder Melissa Whippo on why it’s time to take psychedelic medicine—and women’s health—seriously.
The Guardian: Doctor, Shaman – Adana Omágua Kambeba on Bridging Indigenous and Western Medicine Indigenous Nations Issue Urgent Call to Protect Ayahuasca Psychedelics & Women’s Wellness: A New Frontier in Mental Health In & Through: The Onaya Podcast: #2 — Indigenous Psychedelic-Assisted Therapies (IPAT) – Medicine via myPod When are post-trip difficulties best treated as PTSD?
Building a psychedelic safety network – by Jules Evans What Do People Who Take Ayahuasca Look For?
⋆ The Costa Rica News EE UU niega la aprobación del uso terapéutico de MDMA The Former Presidents of Gabon Consumed Iboga Spiritually | DoubleBlind Mag The paradise island of Fuerteventura is positioned as the epicentre of psychedelic science Netflix Under Fire for Misinformation About Ayahuasca Death Trippy trips: Why psychedelic tourism is the future of wellness travel Harm reduction services at festivals MDMA -Menstrual Moods & Mushrooms Can Magic Mushrooms Take on Menopause?
I took magic mushrooms for the menopause – they restored my joy The Other Side of Veteran Healing: Secondary PTSD and Post-Retreat Family Dynamics A User’s Guide to Therapeutic Psychedelics Acid Gel Tabs Were Cool Once—But WTF Are They? Ayahuasca retreats associated with increases in nature-relatedness Download our Integration Guide Just enter your email in order to download our Integration Guide
According to the current listing, eligibility includes: Independent projects aligned with MAPS' mission in psychedelic harm reduction, drug policy reform, education, research, advocacy, and community-building. Confirm the full requirements in the official notice before applying.
Fiscal Sponsorship Program is funded by Multidisciplinary Association for Psychedelic Studies (MAPS). Verify program details on the funder's official page before applying.
This listing is flagged as international in scope. Check the official notice for country-specific restrictions before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read articleARPA-H selected 13 research teams for EVIDENT, a $139.4M initiative to develop objective clinical endpoints for rapid-acting behavioral health therapies including psilocybin. At least $50M will match state psychedelic research investments under a Trump executive order.
Read articleThe April 18 executive order, ARPA-H EVIDENT initiative, and FDA priority vouchers are reshaping mental health research funding. A guide for grant seekers.
Read article